Report Overview
Immuno-Oncology (I-O) is an innovative area of research that seeks to help the body's own immune system fight cancer. The goal is to address the unmet need for long-term survival in patients with advanced cancers.
The global Immuno-Oncology market size was estimated at USD 43650 million in 2023 and is projected to reach USD 152357.73 million by 2032, exhibiting a CAGR of 14.90% during the forecast period.
North America Immuno-Oncology market size was estimated at USD 14464.69 million in 2023, at a CAGR of 12.77% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Immuno-Oncology market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Immuno-Oncology Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Immuno-Oncology market in any manner.
Global Immuno-Oncology Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Bristol-Myers Squibb
Merck & Co.
Inc.
Roche AG
AstraZeneca
Plc
Sanofi S.A.
Dendreon Pharmaceuticals
Novartis
Gilead Sciences Inc.
Merck KGaA
Market Segmentation (by Type)
Immune Checkpoint Inhibitors
Cytokine-Based Immunotherapy
Cancer Vaccines
CAR-T Cell Therapy
Others
Market Segmentation (by Application)
Hospitals
Drugstores
Others
Geographic Segmentation
� North America (USA, Canada, Mexico)
� Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
� Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
� South America (Brazil, Argentina, Columbia, Rest of South America)
� The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
� Industry drivers, restraints, and opportunities covered in the study
� Neutral perspective on the market performance
� Recent industry trends and developments
� Competitive landscape & strategies of key players
� Potential & niche segments and regions exhibiting promising growth covered
� Historical, current, and projected market size, in terms of value
� In-depth analysis of the Immuno-Oncology Market
� Overview of the regional outlook of the Immuno-Oncology Market:
Key Reasons to Buy this Report:
� Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
� This enables you to anticipate market changes to remain ahead of your competitors
� You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
� The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
� Provision of market value data for each segment and sub-segment
� Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
� Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
� Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
� Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
� The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
� Includes in-depth analysis of the market from various perspectives through Porter�s five forces analysis
� Provides insight into the market through Value Chain
� Market dynamics scenario, along with growth opportunities of the market in the years to come
� 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Immuno-Oncology Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Immuno-Oncology, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Immuno-Oncology
1.2 Key Market Segments
1.2.1 Immuno-Oncology Segment by Type
1.2.2 Immuno-Oncology Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Immuno-Oncology Market Overview
2.1 Global Market Overview
2.1.1 Global Immuno-Oncology Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Immuno-Oncology Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Immuno-Oncology Market Competitive Landscape
3.1 Global Immuno-Oncology Sales by Manufacturers (2019-2025)
3.2 Global Immuno-Oncology Revenue Market Share by Manufacturers (2019-2025)
3.3 Immuno-Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Immuno-Oncology Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Immuno-Oncology Sales Sites, Area Served, Product Type
3.6 Immuno-Oncology Market Competitive Situation and Trends
3.6.1 Immuno-Oncology Market Concentration Rate
3.6.2 Global 5 and 10 Largest Immuno-Oncology Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Immuno-Oncology Industry Chain Analysis
4.1 Immuno-Oncology Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Immuno-Oncology Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Immuno-Oncology Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Immuno-Oncology Sales Market Share by Type (2019-2025)
6.3 Global Immuno-Oncology Market Size Market Share by Type (2019-2025)
6.4 Global Immuno-Oncology Price by Type (2019-2025)
7 Immuno-Oncology Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Immuno-Oncology Market Sales by Application (2019-2025)
7.3 Global Immuno-Oncology Market Size (M USD) by Application (2019-2025)
7.4 Global Immuno-Oncology Sales Growth Rate by Application (2019-2025)
8 Immuno-Oncology Market Consumption by Region
8.1 Global Immuno-Oncology Sales by Region
8.1.1 Global Immuno-Oncology Sales by Region
8.1.2 Global Immuno-Oncology Sales Market Share by Region
8.2 North America
8.2.1 North America Immuno-Oncology Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Immuno-Oncology Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Immuno-Oncology Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Immuno-Oncology Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Immuno-Oncology Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Immuno-Oncology Market Production by Region
9.1 Global Production of Immuno-Oncology by Region (2019-2025)
9.2 Global Immuno-Oncology Revenue Market Share by Region (2019-2025)
9.3 Global Immuno-Oncology Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Immuno-Oncology Production
9.4.1 North America Immuno-Oncology Production Growth Rate (2019-2025)
9.4.2 North America Immuno-Oncology Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Immuno-Oncology Production
9.5.1 Europe Immuno-Oncology Production Growth Rate (2019-2025)
9.5.2 Europe Immuno-Oncology Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Immuno-Oncology Production (2019-2025)
9.6.1 Japan Immuno-Oncology Production Growth Rate (2019-2025)
9.6.2 Japan Immuno-Oncology Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Immuno-Oncology Production (2019-2025)
9.7.1 China Immuno-Oncology Production Growth Rate (2019-2025)
9.7.2 China Immuno-Oncology Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Bristol-Myers Squibb
10.1.1 Bristol-Myers Squibb Immuno-Oncology Basic Information
10.1.2 Bristol-Myers Squibb Immuno-Oncology Product Overview
10.1.3 Bristol-Myers Squibb Immuno-Oncology Product Market Performance
10.1.4 Bristol-Myers Squibb Business Overview
10.1.5 Bristol-Myers Squibb Immuno-Oncology SWOT Analysis
10.1.6 Bristol-Myers Squibb Recent Developments
10.2 Merck and Co.
10.2.1 Merck and Co. Immuno-Oncology Basic Information
10.2.2 Merck and Co. Immuno-Oncology Product Overview
10.2.3 Merck and Co. Immuno-Oncology Product Market Performance
10.2.4 Merck and Co. Business Overview
10.2.5 Merck and Co. Immuno-Oncology SWOT Analysis
10.2.6 Merck and Co. Recent Developments
10.3 Inc.
10.3.1 Inc. Immuno-Oncology Basic Information
10.3.2 Inc. Immuno-Oncology Product Overview
10.3.3 Inc. Immuno-Oncology Product Market Performance
10.3.4 Inc. Immuno-Oncology SWOT Analysis
10.3.5 Inc. Business Overview
10.3.6 Inc. Recent Developments
10.4 Roche AG
10.4.1 Roche AG Immuno-Oncology Basic Information
10.4.2 Roche AG Immuno-Oncology Product Overview
10.4.3 Roche AG Immuno-Oncology Product Market Performance
10.4.4 Roche AG Business Overview
10.4.5 Roche AG Recent Developments
10.5 AstraZeneca
10.5.1 AstraZeneca Immuno-Oncology Basic Information
10.5.2 AstraZeneca Immuno-Oncology Product Overview
10.5.3 AstraZeneca Immuno-Oncology Product Market Performance
10.5.4 AstraZeneca Business Overview
10.5.5 AstraZeneca Recent Developments
10.6 Plc
10.6.1 Plc Immuno-Oncology Basic Information
10.6.2 Plc Immuno-Oncology Product Overview
10.6.3 Plc Immuno-Oncology Product Market Performance
10.6.4 Plc Business Overview
10.6.5 Plc Recent Developments
10.7 Sanofi S.A.
10.7.1 Sanofi S.A. Immuno-Oncology Basic Information
10.7.2 Sanofi S.A. Immuno-Oncology Product Overview
10.7.3 Sanofi S.A. Immuno-Oncology Product Market Performance
10.7.4 Sanofi S.A. Business Overview
10.7.5 Sanofi S.A. Recent Developments
10.8 Dendreon Pharmaceuticals
10.8.1 Dendreon Pharmaceuticals Immuno-Oncology Basic Information
10.8.2 Dendreon Pharmaceuticals Immuno-Oncology Product Overview
10.8.3 Dendreon Pharmaceuticals Immuno-Oncology Product Market Performance
10.8.4 Dendreon Pharmaceuticals Business Overview
10.8.5 Dendreon Pharmaceuticals Recent Developments
10.9 Novartis
10.9.1 Novartis Immuno-Oncology Basic Information
10.9.2 Novartis Immuno-Oncology Product Overview
10.9.3 Novartis Immuno-Oncology Product Market Performance
10.9.4 Novartis Business Overview
10.9.5 Novartis Recent Developments
10.10 Gilead Sciences Inc.
10.10.1 Gilead Sciences Inc. Immuno-Oncology Basic Information
10.10.2 Gilead Sciences Inc. Immuno-Oncology Product Overview
10.10.3 Gilead Sciences Inc. Immuno-Oncology Product Market Performance
10.10.4 Gilead Sciences Inc. Business Overview
10.10.5 Gilead Sciences Inc. Recent Developments
10.11 Merck KGaA
10.11.1 Merck KGaA Immuno-Oncology Basic Information
10.11.2 Merck KGaA Immuno-Oncology Product Overview
10.11.3 Merck KGaA Immuno-Oncology Product Market Performance
10.11.4 Merck KGaA Business Overview
10.11.5 Merck KGaA Recent Developments
11 Immuno-Oncology Market Forecast by Region
11.1 Global Immuno-Oncology Market Size Forecast
11.2 Global Immuno-Oncology Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Immuno-Oncology Market Size Forecast by Country
11.2.3 Asia Pacific Immuno-Oncology Market Size Forecast by Region
11.2.4 South America Immuno-Oncology Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Immuno-Oncology by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Immuno-Oncology Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Immuno-Oncology by Type (2025-2032)
12.1.2 Global Immuno-Oncology Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Immuno-Oncology by Type (2025-2032)
12.2 Global Immuno-Oncology Market Forecast by Application (2025-2032)
12.2.1 Global Immuno-Oncology Sales (K Units) Forecast by Application
12.2.2 Global Immuno-Oncology Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Immuno-Oncology Market Size Comparison by Region (M USD)
Table 5. Global Immuno-Oncology Sales (K Units) by Manufacturers (2019-2025)
Table 6. Global Immuno-Oncology Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Immuno-Oncology Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Immuno-Oncology Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-Oncology as of 2022)
Table 10. Global Market Immuno-Oncology Average Price (USD/Unit) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Immuno-Oncology Sales Sites and Area Served
Table 12. Manufacturers Immuno-Oncology Product Type
Table 13. Global Immuno-Oncology Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Immuno-Oncology
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Immuno-Oncology Market Challenges
Table 22. Global Immuno-Oncology Sales by Type (K Units)
Table 23. Global Immuno-Oncology Market Size by Type (M USD)
Table 24. Global Immuno-Oncology Sales (K Units) by Type (2019-2025)
Table 25. Global Immuno-Oncology Sales Market Share by Type (2019-2025)
Table 26. Global Immuno-Oncology Market Size (M USD) by Type (2019-2025)
Table 27. Global Immuno-Oncology Market Size Share by Type (2019-2025)
Table 28. Global Immuno-Oncology Price (USD/Unit) by Type (2019-2025)
Table 29. Global Immuno-Oncology Sales (K Units) by Application
Table 30. Global Immuno-Oncology Market Size by Application
Table 31. Global Immuno-Oncology Sales by Application (2019-2025) & (K Units)
Table 32. Global Immuno-Oncology Sales Market Share by Application (2019-2025)
Table 33. Global Immuno-Oncology Sales by Application (2019-2025) & (M USD)
Table 34. Global Immuno-Oncology Market Share by Application (2019-2025)
Table 35. Global Immuno-Oncology Sales Growth Rate by Application (2019-2025)
Table 36. Global Immuno-Oncology Sales by Region (2019-2025) & (K Units)
Table 37. Global Immuno-Oncology Sales Market Share by Region (2019-2025)
Table 38. North America Immuno-Oncology Sales by Country (2019-2025) & (K Units)
Table 39. Europe Immuno-Oncology Sales by Country (2019-2025) & (K Units)
Table 40. Asia Pacific Immuno-Oncology Sales by Region (2019-2025) & (K Units)
Table 41. South America Immuno-Oncology Sales by Country (2019-2025) & (K Units)
Table 42. Middle East and Africa Immuno-Oncology Sales by Region (2019-2025) & (K Units)
Table 43. Global Immuno-Oncology Production (K Units) by Region (2019-2025)
Table 44. Global Immuno-Oncology Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Immuno-Oncology Revenue Market Share by Region (2019-2025)
Table 46. Global Immuno-Oncology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 47. North America Immuno-Oncology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 48. Europe Immuno-Oncology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 49. Japan Immuno-Oncology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 50. China Immuno-Oncology Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 51. Bristol-Myers Squibb Immuno-Oncology Basic Information
Table 52. Bristol-Myers Squibb Immuno-Oncology Product Overview
Table 53. Bristol-Myers Squibb Immuno-Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 54. Bristol-Myers Squibb Business Overview
Table 55. Bristol-Myers Squibb Immuno-Oncology SWOT Analysis
Table 56. Bristol-Myers Squibb Recent Developments
Table 57. Merck and Co. Immuno-Oncology Basic Information
Table 58. Merck and Co. Immuno-Oncology Product Overview
Table 59. Merck and Co. Immuno-Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 60. Merck and Co. Business Overview
Table 61. Merck and Co. Immuno-Oncology SWOT Analysis
Table 62. Merck and Co. Recent Developments
Table 63. Inc. Immuno-Oncology Basic Information
Table 64. Inc. Immuno-Oncology Product Overview
Table 65. Inc. Immuno-Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 66. Inc. Immuno-Oncology SWOT Analysis
Table 67. Inc. Business Overview
Table 68. Inc. Recent Developments
Table 69. Roche AG Immuno-Oncology Basic Information
Table 70. Roche AG Immuno-Oncology Product Overview
Table 71. Roche AG Immuno-Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 72. Roche AG Business Overview
Table 73. Roche AG Recent Developments
Table 74. AstraZeneca Immuno-Oncology Basic Information
Table 75. AstraZeneca Immuno-Oncology Product Overview
Table 76. AstraZeneca Immuno-Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 77. AstraZeneca Business Overview
Table 78. AstraZeneca Recent Developments
Table 79. Plc Immuno-Oncology Basic Information
Table 80. Plc Immuno-Oncology Product Overview
Table 81. Plc Immuno-Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 82. Plc Business Overview
Table 83. Plc Recent Developments
Table 84. Sanofi S.A. Immuno-Oncology Basic Information
Table 85. Sanofi S.A. Immuno-Oncology Product Overview
Table 86. Sanofi S.A. Immuno-Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 87. Sanofi S.A. Business Overview
Table 88. Sanofi S.A. Recent Developments
Table 89. Dendreon Pharmaceuticals Immuno-Oncology Basic Information
Table 90. Dendreon Pharmaceuticals Immuno-Oncology Product Overview
Table 91. Dendreon Pharmaceuticals Immuno-Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 92. Dendreon Pharmaceuticals Business Overview
Table 93. Dendreon Pharmaceuticals Recent Developments
Table 94. Novartis Immuno-Oncology Basic Information
Table 95. Novartis Immuno-Oncology Product Overview
Table 96. Novartis Immuno-Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 97. Novartis Business Overview
Table 98. Novartis Recent Developments
Table 99. Gilead Sciences Inc. Immuno-Oncology Basic Information
Table 100. Gilead Sciences Inc. Immuno-Oncology Product Overview
Table 101. Gilead Sciences Inc. Immuno-Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 102. Gilead Sciences Inc. Business Overview
Table 103. Gilead Sciences Inc. Recent Developments
Table 104. Merck KGaA Immuno-Oncology Basic Information
Table 105. Merck KGaA Immuno-Oncology Product Overview
Table 106. Merck KGaA Immuno-Oncology Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 107. Merck KGaA Business Overview
Table 108. Merck KGaA Recent Developments
Table 109. Global Immuno-Oncology Sales Forecast by Region (2025-2032) & (K Units)
Table 110. Global Immuno-Oncology Market Size Forecast by Region (2025-2032) & (M USD)
Table 111. North America Immuno-Oncology Sales Forecast by Country (2025-2032) & (K Units)
Table 112. North America Immuno-Oncology Market Size Forecast by Country (2025-2032) & (M USD)
Table 113. Europe Immuno-Oncology Sales Forecast by Country (2025-2032) & (K Units)
Table 114. Europe Immuno-Oncology Market Size Forecast by Country (2025-2032) & (M USD)
Table 115. Asia Pacific Immuno-Oncology Sales Forecast by Region (2025-2032) & (K Units)
Table 116. Asia Pacific Immuno-Oncology Market Size Forecast by Region (2025-2032) & (M USD)
Table 117. South America Immuno-Oncology Sales Forecast by Country (2025-2032) & (K Units)
Table 118. South America Immuno-Oncology Market Size Forecast by Country (2025-2032) & (M USD)
Table 119. Middle East and Africa Immuno-Oncology Consumption Forecast by Country (2025-2032) & (Units)
Table 120. Middle East and Africa Immuno-Oncology Market Size Forecast by Country (2025-2032) & (M USD)
Table 121. Global Immuno-Oncology Sales Forecast by Type (2025-2032) & (K Units)
Table 122. Global Immuno-Oncology Market Size Forecast by Type (2025-2032) & (M USD)
Table 123. Global Immuno-Oncology Price Forecast by Type (2025-2032) & (USD/Unit)
Table 124. Global Immuno-Oncology Sales (K Units) Forecast by Application (2025-2032)
Table 125. Global Immuno-Oncology Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Immuno-Oncology
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Immuno-Oncology Market Size (M USD), 2019-2032
Figure 5. Global Immuno-Oncology Market Size (M USD) (2019-2032)
Figure 6. Global Immuno-Oncology Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Immuno-Oncology Market Size by Country (M USD)
Figure 11. Immuno-Oncology Sales Share by Manufacturers in 2023
Figure 12. Global Immuno-Oncology Revenue Share by Manufacturers in 2023
Figure 13. Immuno-Oncology Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Immuno-Oncology Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Immuno-Oncology Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Immuno-Oncology Market Share by Type
Figure 18. Sales Market Share of Immuno-Oncology by Type (2019-2025)
Figure 19. Sales Market Share of Immuno-Oncology by Type in 2023
Figure 20. Market Size Share of Immuno-Oncology by Type (2019-2025)
Figure 21. Market Size Market Share of Immuno-Oncology by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Immuno-Oncology Market Share by Application
Figure 24. Global Immuno-Oncology Sales Market Share by Application (2019-2025)
Figure 25. Global Immuno-Oncology Sales Market Share by Application in 2023
Figure 26. Global Immuno-Oncology Market Share by Application (2019-2025)
Figure 27. Global Immuno-Oncology Market Share by Application in 2023
Figure 28. Global Immuno-Oncology Sales Growth Rate by Application (2019-2025)
Figure 29. Global Immuno-Oncology Sales Market Share by Region (2019-2025)
Figure 30. North America Immuno-Oncology Sales and Growth Rate (2019-2025) & (K Units)
Figure 31. North America Immuno-Oncology Sales Market Share by Country in 2023
Figure 32. U.S. Immuno-Oncology Sales and Growth Rate (2019-2025) & (K Units)
Figure 33. Canada Immuno-Oncology Sales (K Units) and Growth Rate (2019-2025)
Figure 34. Mexico Immuno-Oncology Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Immuno-Oncology Sales and Growth Rate (2019-2025) & (K Units)
Figure 36. Europe Immuno-Oncology Sales Market Share by Country in 2023
Figure 37. Germany Immuno-Oncology Sales and Growth Rate (2019-2025) & (K Units)
Figure 38. France Immuno-Oncology Sales and Growth Rate (2019-2025) & (K Units)
Figure 39. U.K. Immuno-Oncology Sales and Growth Rate (2019-2025) & (K Units)
Figure 40. Italy Immuno-Oncology Sales and Growth Rate (2019-2025) & (K Units)
Figure 41. Russia Immuno-Oncology Sales and Growth Rate (2019-2025) & (K Units)
Figure 42. Asia Pacific Immuno-Oncology Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Immuno-Oncology Sales Market Share by Region in 2023
Figure 44. China Immuno-Oncology Sales and Growth Rate (2019-2025) & (K Units)
Figure 45. Japan Immuno-Oncology Sales and Growth Rate (2019-2025) & (K Units)
Figure 46. South Korea Immuno-Oncology Sales and Growth Rate (2019-2025) & (K Units)
Figure 47. India Immuno-Oncology Sales and Growth Rate (2019-2025) & (K Units)
Figure 48. Southeast Asia Immuno-Oncology Sales and Growth Rate (2019-2025) & (K Units)
Figure 49. South America Immuno-Oncology Sales and Growth Rate (K Units)
Figure 50. South America Immuno-Oncology Sales Market Share by Country in 2023
Figure 51. Brazil Immuno-Oncology Sales and Growth Rate (2019-2025) & (K Units)
Figure 52. Argentina Immuno-Oncology Sales and Growth Rate (2019-2025) & (K Units)
Figure 53. Columbia Immuno-Oncology Sales and Growth Rate (2019-2025) & (K Units)
Figure 54. Middle East and Africa Immuno-Oncology Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Immuno-Oncology Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Immuno-Oncology Sales and Growth Rate (2019-2025) & (K Units)
Figure 57. UAE Immuno-Oncology Sales and Growth Rate (2019-2025) & (K Units)
Figure 58. Egypt Immuno-Oncology Sales and Growth Rate (2019-2025) & (K Units)
Figure 59. Nigeria Immuno-Oncology Sales and Growth Rate (2019-2025) & (K Units)
Figure 60. South Africa Immuno-Oncology Sales and Growth Rate (2019-2025) & (K Units)
Figure 61. Global Immuno-Oncology Production Market Share by Region (2019-2025)
Figure 62. North America Immuno-Oncology Production (K Units) Growth Rate (2019-2025)
Figure 63. Europe Immuno-Oncology Production (K Units) Growth Rate (2019-2025)
Figure 64. Japan Immuno-Oncology Production (K Units) Growth Rate (2019-2025)
Figure 65. China Immuno-Oncology Production (K Units) Growth Rate (2019-2025)
Figure 66. Global Immuno-Oncology Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Immuno-Oncology Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Immuno-Oncology Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Immuno-Oncology Market Share Forecast by Type (2025-2032)
Figure 70. Global Immuno-Oncology Sales Forecast by Application (2025-2032)
Figure 71. Global Immuno-Oncology Market Share Forecast by Application (2025-2032)
